Surfactant use in late preterm infants: a survey among Belgian neonatologists
Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all ( n = 102) Belgian neonatologists to identify the use of surfactant in LPT infants suffering from several respiratory pa...
Gespeichert in:
| Veröffentlicht in: | European journal of pediatrics 2021-03, Vol.180 (3), p.885-892 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 892 |
|---|---|
| container_issue | 3 |
| container_start_page | 885 |
| container_title | European journal of pediatrics |
| container_volume | 180 |
| creator | Cornette, L. Mulder, A. Debeer, A. Malfilâtre, G. Rigo, V. Cools, F. Danhaive, O. |
| description | Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all (
n
= 102) Belgian neonatologists to identify the use of surfactant in LPT infants suffering from several respiratory pathologies. The survey used clearly defined clinical cases and resulted in a 86% response rate. Neonatologists adhere to the 200 mg/kg initial surfactant dosing scheme. Surfactant is widely used in respiratory distress syndrome (70.1%), but there is less unanimity on its use in meconium aspiration syndrome (58.0%), transient tachypnoea of the newborn (30.6%), congenital pneumonia (27.2%) and congenital diaphragmatic hernia (8.6%). Respondents adhere to the European guideline of a timely referral to a newborn intensive care unit (non-invasive ventilation and FiO
2
> 0.30 at 12 h of age), in order to minimise the risk of deterioration.
Conclusion
: We demonstrate a wide variety in the use of surfactant within LPT infants. The majority of Belgian neonatologists therefore urge for an investment in multi-centre trials on surfactant administration in LPT infants, in order to create an evidence-based practice as well as to reduce the strain on health care budgets.
Trial registration
:
https://clinicaltrials.gov
What is Known:
• Any late preterm (LPT) infant with respiratory distress needs a timely referral to a neonatal intensive care unit in case of non-invasive ventilation and FiO
2
> 0.30 at 12 h of life, in order to minimise the risk of acute deterioration as well as chronic lung disease.
• Any modest increase in morbidity in the sizeable group of LPT infants exerts a significant strain on health care budgets.
What is New:
• We report the attitudes and opinions of Belgian neonatologists about the use of surfactant in LPT infants suffering from several respiratory diseases.
• Our survey demonstrates a significant variability in practice between neonatologists during treatment of respiratory pathologies in LPT infants. This highlights an urgent need for univocal therapeutic lines. |
| doi_str_mv | 10.1007/s00431-020-03806-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_sprin</sourceid><recordid>TN_cdi_proquest_journals_2489907026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2445969775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-8177ec3df01ae699c39deaf322f4870fd07f8679e1099d8e4ae0b158028c07fa3</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEotvCH-CAInFBqgJjO4ltDkiw4ksq4gCcLceZBFeJvdjOov573E3ZAgeEL7Y1zzuemddF8YjAMwLAn0eAmpEKKFTABLQVuVNsSM1oRYC3d4sNsBqqlkh5UpzGeAlZJIm4X5wwKjnQmm2Kj5-XMGiTtEvlErG0rpx0wnIXMGGY833Iofii1GVcwh6vSj17N5avcRqtdqVD73Tykx9tTPFBcW_QU8SHN_tZ8fXtmy_b99XFp3cftq8uKtMQkSpBOEfD-gGIxlZKw2SPemCUDrXgMPTAB9FyiQSk7AXWGqEjjQAqTA5pdla8XPPulm7G3qBLQU9qF-ysw5Xy2qo_I85-U6PfK94QQjnkBGxNMFkcUfnQWbWnB-HhvEyj0kZ1qChthaJNwwjNqqc3zwb_fcGY1GyjwWnSeQxLVLSuG9lKzpuMPvkLvfRLcHkomRJSQp5_mym6Uib4GAMOxxYIqGuP1eqxyh6rg8eKZNHj35s_Sn6ZmgGxAj-w80M0Fp3BI5Z_QcNpc11DXmRrk07Wu61fXMrS8_-X3k4xZsKNGG6b_Ef9PwGE2tKk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489907026</pqid></control><display><type>article</type><title>Surfactant use in late preterm infants: a survey among Belgian neonatologists</title><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>SpringerLink Journals - AutoHoldings</source><creator>Cornette, L. ; Mulder, A. ; Debeer, A. ; Malfilâtre, G. ; Rigo, V. ; Cools, F. ; Danhaive, O.</creator><creatorcontrib>Cornette, L. ; Mulder, A. ; Debeer, A. ; Malfilâtre, G. ; Rigo, V. ; Cools, F. ; Danhaive, O.</creatorcontrib><description>Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all (
n
= 102) Belgian neonatologists to identify the use of surfactant in LPT infants suffering from several respiratory pathologies. The survey used clearly defined clinical cases and resulted in a 86% response rate. Neonatologists adhere to the 200 mg/kg initial surfactant dosing scheme. Surfactant is widely used in respiratory distress syndrome (70.1%), but there is less unanimity on its use in meconium aspiration syndrome (58.0%), transient tachypnoea of the newborn (30.6%), congenital pneumonia (27.2%) and congenital diaphragmatic hernia (8.6%). Respondents adhere to the European guideline of a timely referral to a newborn intensive care unit (non-invasive ventilation and FiO
2
> 0.30 at 12 h of age), in order to minimise the risk of deterioration.
Conclusion
: We demonstrate a wide variety in the use of surfactant within LPT infants. The majority of Belgian neonatologists therefore urge for an investment in multi-centre trials on surfactant administration in LPT infants, in order to create an evidence-based practice as well as to reduce the strain on health care budgets.
Trial registration
:
https://clinicaltrials.gov
What is Known:
• Any late preterm (LPT) infant with respiratory distress needs a timely referral to a neonatal intensive care unit in case of non-invasive ventilation and FiO
2
> 0.30 at 12 h of life, in order to minimise the risk of acute deterioration as well as chronic lung disease.
• Any modest increase in morbidity in the sizeable group of LPT infants exerts a significant strain on health care budgets.
What is New:
• We report the attitudes and opinions of Belgian neonatologists about the use of surfactant in LPT infants suffering from several respiratory diseases.
• Our survey demonstrates a significant variability in practice between neonatologists during treatment of respiratory pathologies in LPT infants. This highlights an urgent need for univocal therapeutic lines.</description><identifier>ISSN: 0340-6199</identifier><identifier>ISSN: 1432-1076</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s00431-020-03806-1</identifier><identifier>PMID: 32970243</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Clinical trials ; Congenital diseases ; Hernia ; Human health sciences ; Infants ; Intensive care ; Late preterm infant ; Life Sciences & Biomedicine ; Lung diseases ; Meconium ; Medicine ; Medicine & Public Health ; Morbidity ; Nationwide survey ; Neonates ; Newborn babies ; Original ; Original Article ; Pediatrics ; Premature babies ; Pédiatrie ; Respiratory diseases ; Respiratory distress syndrome ; Science & Technology ; Sciences de la santé humaine ; Surfactant therapy ; Surfactants ; Ventilators</subject><ispartof>European journal of pediatrics, 2021-03, Vol.180 (3), p.885-892</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>6</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000572589900001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c518t-8177ec3df01ae699c39deaf322f4870fd07f8679e1099d8e4ae0b158028c07fa3</citedby><cites>FETCH-LOGICAL-c518t-8177ec3df01ae699c39deaf322f4870fd07f8679e1099d8e4ae0b158028c07fa3</cites><orcidid>0000-0002-3484-5752 ; 0000-0001-8625-4359 ; 0000-0002-6581-7009 ; 0000-0001-9418-8160</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00431-020-03806-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00431-020-03806-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,315,781,785,886,27929,27930,39263,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32970243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cornette, L.</creatorcontrib><creatorcontrib>Mulder, A.</creatorcontrib><creatorcontrib>Debeer, A.</creatorcontrib><creatorcontrib>Malfilâtre, G.</creatorcontrib><creatorcontrib>Rigo, V.</creatorcontrib><creatorcontrib>Cools, F.</creatorcontrib><creatorcontrib>Danhaive, O.</creatorcontrib><title>Surfactant use in late preterm infants: a survey among Belgian neonatologists</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><addtitle>EUR J PEDIATR</addtitle><addtitle>Eur J Pediatr</addtitle><description>Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all (
n
= 102) Belgian neonatologists to identify the use of surfactant in LPT infants suffering from several respiratory pathologies. The survey used clearly defined clinical cases and resulted in a 86% response rate. Neonatologists adhere to the 200 mg/kg initial surfactant dosing scheme. Surfactant is widely used in respiratory distress syndrome (70.1%), but there is less unanimity on its use in meconium aspiration syndrome (58.0%), transient tachypnoea of the newborn (30.6%), congenital pneumonia (27.2%) and congenital diaphragmatic hernia (8.6%). Respondents adhere to the European guideline of a timely referral to a newborn intensive care unit (non-invasive ventilation and FiO
2
> 0.30 at 12 h of age), in order to minimise the risk of deterioration.
Conclusion
: We demonstrate a wide variety in the use of surfactant within LPT infants. The majority of Belgian neonatologists therefore urge for an investment in multi-centre trials on surfactant administration in LPT infants, in order to create an evidence-based practice as well as to reduce the strain on health care budgets.
Trial registration
:
https://clinicaltrials.gov
What is Known:
• Any late preterm (LPT) infant with respiratory distress needs a timely referral to a neonatal intensive care unit in case of non-invasive ventilation and FiO
2
> 0.30 at 12 h of life, in order to minimise the risk of acute deterioration as well as chronic lung disease.
• Any modest increase in morbidity in the sizeable group of LPT infants exerts a significant strain on health care budgets.
What is New:
• We report the attitudes and opinions of Belgian neonatologists about the use of surfactant in LPT infants suffering from several respiratory diseases.
• Our survey demonstrates a significant variability in practice between neonatologists during treatment of respiratory pathologies in LPT infants. This highlights an urgent need for univocal therapeutic lines.</description><subject>Clinical trials</subject><subject>Congenital diseases</subject><subject>Hernia</subject><subject>Human health sciences</subject><subject>Infants</subject><subject>Intensive care</subject><subject>Late preterm infant</subject><subject>Life Sciences & Biomedicine</subject><subject>Lung diseases</subject><subject>Meconium</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Morbidity</subject><subject>Nationwide survey</subject><subject>Neonates</subject><subject>Newborn babies</subject><subject>Original</subject><subject>Original Article</subject><subject>Pediatrics</subject><subject>Premature babies</subject><subject>Pédiatrie</subject><subject>Respiratory diseases</subject><subject>Respiratory distress syndrome</subject><subject>Science & Technology</subject><subject>Sciences de la santé humaine</subject><subject>Surfactant therapy</subject><subject>Surfactants</subject><subject>Ventilators</subject><issn>0340-6199</issn><issn>1432-1076</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkk1v1DAQhiMEotvCH-CAInFBqgJjO4ltDkiw4ksq4gCcLceZBFeJvdjOov573E3ZAgeEL7Y1zzuemddF8YjAMwLAn0eAmpEKKFTABLQVuVNsSM1oRYC3d4sNsBqqlkh5UpzGeAlZJIm4X5wwKjnQmm2Kj5-XMGiTtEvlErG0rpx0wnIXMGGY833Iofii1GVcwh6vSj17N5avcRqtdqVD73Tykx9tTPFBcW_QU8SHN_tZ8fXtmy_b99XFp3cftq8uKtMQkSpBOEfD-gGIxlZKw2SPemCUDrXgMPTAB9FyiQSk7AXWGqEjjQAqTA5pdla8XPPulm7G3qBLQU9qF-ysw5Xy2qo_I85-U6PfK94QQjnkBGxNMFkcUfnQWbWnB-HhvEyj0kZ1qChthaJNwwjNqqc3zwb_fcGY1GyjwWnSeQxLVLSuG9lKzpuMPvkLvfRLcHkomRJSQp5_mym6Uib4GAMOxxYIqGuP1eqxyh6rg8eKZNHj35s_Sn6ZmgGxAj-w80M0Fp3BI5Z_QcNpc11DXmRrk07Wu61fXMrS8_-X3k4xZsKNGG6b_Ef9PwGE2tKk</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Cornette, L.</creator><creator>Mulder, A.</creator><creator>Debeer, A.</creator><creator>Malfilâtre, G.</creator><creator>Rigo, V.</creator><creator>Cools, F.</creator><creator>Danhaive, O.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature</general><general>Springer Nature B.V</general><general>Springer</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>Q33</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3484-5752</orcidid><orcidid>https://orcid.org/0000-0001-8625-4359</orcidid><orcidid>https://orcid.org/0000-0002-6581-7009</orcidid><orcidid>https://orcid.org/0000-0001-9418-8160</orcidid></search><sort><creationdate>20210301</creationdate><title>Surfactant use in late preterm infants: a survey among Belgian neonatologists</title><author>Cornette, L. ; Mulder, A. ; Debeer, A. ; Malfilâtre, G. ; Rigo, V. ; Cools, F. ; Danhaive, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-8177ec3df01ae699c39deaf322f4870fd07f8679e1099d8e4ae0b158028c07fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Clinical trials</topic><topic>Congenital diseases</topic><topic>Hernia</topic><topic>Human health sciences</topic><topic>Infants</topic><topic>Intensive care</topic><topic>Late preterm infant</topic><topic>Life Sciences & Biomedicine</topic><topic>Lung diseases</topic><topic>Meconium</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Morbidity</topic><topic>Nationwide survey</topic><topic>Neonates</topic><topic>Newborn babies</topic><topic>Original</topic><topic>Original Article</topic><topic>Pediatrics</topic><topic>Premature babies</topic><topic>Pédiatrie</topic><topic>Respiratory diseases</topic><topic>Respiratory distress syndrome</topic><topic>Science & Technology</topic><topic>Sciences de la santé humaine</topic><topic>Surfactant therapy</topic><topic>Surfactants</topic><topic>Ventilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cornette, L.</creatorcontrib><creatorcontrib>Mulder, A.</creatorcontrib><creatorcontrib>Debeer, A.</creatorcontrib><creatorcontrib>Malfilâtre, G.</creatorcontrib><creatorcontrib>Rigo, V.</creatorcontrib><creatorcontrib>Cools, F.</creatorcontrib><creatorcontrib>Danhaive, O.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cornette, L.</au><au>Mulder, A.</au><au>Debeer, A.</au><au>Malfilâtre, G.</au><au>Rigo, V.</au><au>Cools, F.</au><au>Danhaive, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surfactant use in late preterm infants: a survey among Belgian neonatologists</atitle><jtitle>European journal of pediatrics</jtitle><stitle>Eur J Pediatr</stitle><stitle>EUR J PEDIATR</stitle><addtitle>Eur J Pediatr</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>180</volume><issue>3</issue><spage>885</spage><epage>892</epage><pages>885-892</pages><issn>0340-6199</issn><issn>1432-1076</issn><eissn>1432-1076</eissn><abstract>Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all (
n
= 102) Belgian neonatologists to identify the use of surfactant in LPT infants suffering from several respiratory pathologies. The survey used clearly defined clinical cases and resulted in a 86% response rate. Neonatologists adhere to the 200 mg/kg initial surfactant dosing scheme. Surfactant is widely used in respiratory distress syndrome (70.1%), but there is less unanimity on its use in meconium aspiration syndrome (58.0%), transient tachypnoea of the newborn (30.6%), congenital pneumonia (27.2%) and congenital diaphragmatic hernia (8.6%). Respondents adhere to the European guideline of a timely referral to a newborn intensive care unit (non-invasive ventilation and FiO
2
> 0.30 at 12 h of age), in order to minimise the risk of deterioration.
Conclusion
: We demonstrate a wide variety in the use of surfactant within LPT infants. The majority of Belgian neonatologists therefore urge for an investment in multi-centre trials on surfactant administration in LPT infants, in order to create an evidence-based practice as well as to reduce the strain on health care budgets.
Trial registration
:
https://clinicaltrials.gov
What is Known:
• Any late preterm (LPT) infant with respiratory distress needs a timely referral to a neonatal intensive care unit in case of non-invasive ventilation and FiO
2
> 0.30 at 12 h of life, in order to minimise the risk of acute deterioration as well as chronic lung disease.
• Any modest increase in morbidity in the sizeable group of LPT infants exerts a significant strain on health care budgets.
What is New:
• We report the attitudes and opinions of Belgian neonatologists about the use of surfactant in LPT infants suffering from several respiratory diseases.
• Our survey demonstrates a significant variability in practice between neonatologists during treatment of respiratory pathologies in LPT infants. This highlights an urgent need for univocal therapeutic lines.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32970243</pmid><doi>10.1007/s00431-020-03806-1</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3484-5752</orcidid><orcidid>https://orcid.org/0000-0001-8625-4359</orcidid><orcidid>https://orcid.org/0000-0002-6581-7009</orcidid><orcidid>https://orcid.org/0000-0001-9418-8160</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0340-6199 |
| ispartof | European journal of pediatrics, 2021-03, Vol.180 (3), p.885-892 |
| issn | 0340-6199 1432-1076 1432-1076 |
| language | eng |
| recordid | cdi_proquest_journals_2489907026 |
| source | Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; SpringerLink Journals - AutoHoldings |
| subjects | Clinical trials Congenital diseases Hernia Human health sciences Infants Intensive care Late preterm infant Life Sciences & Biomedicine Lung diseases Meconium Medicine Medicine & Public Health Morbidity Nationwide survey Neonates Newborn babies Original Original Article Pediatrics Premature babies Pédiatrie Respiratory diseases Respiratory distress syndrome Science & Technology Sciences de la santé humaine Surfactant therapy Surfactants Ventilators |
| title | Surfactant use in late preterm infants: a survey among Belgian neonatologists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T08%3A40%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surfactant%20use%20in%20late%20preterm%20infants:%20a%20survey%20among%20Belgian%20neonatologists&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=Cornette,%20L.&rft.date=2021-03-01&rft.volume=180&rft.issue=3&rft.spage=885&rft.epage=892&rft.pages=885-892&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/s00431-020-03806-1&rft_dat=%3Cproquest_sprin%3E2445969775%3C/proquest_sprin%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489907026&rft_id=info:pmid/32970243&rfr_iscdi=true |